Lead PI: Dr Graeme J Hankey and Associate Professor Maree L. Hackett
No. of Patients Currently Recruited: 246 No. of Patients Required: 1600
An Australian-lead investigator initiated, multi-centre, prospective, randomized, parallel group, double blind placebo-controlled trial to establish the effect(s) of routine administration of fluoxetine (20mg once daily) for 6 months in patients with recent stroke on functional outcome at 6 months and one year.
ANZCTR No: ACTRN12611000774921